Get updates to this list
You’re signing up to all partnering opportunity alerts for:
Please check your inbox
Thank you for verifying your email. We have sent you a confirmation email containing a 6 digit verification code to complete your subscription
You've successfully created a subscription
The search results below each have a summary which you may find useful
in determining if the opportunity is what you’re looking for.
Certain diseases result in fibrosis of affected tissue. This 'scarring' causes reduced function compared to healthy tissue, which contributes to disease pathology. Wnt signalling is known to be important for tissue remodelling, such as that... more
A research institute from northern Germany, active in metrology, has developed a traceable, spatial calibration technology which helps to determine calibration of therapeutic ultrasound devices factors more easily.... more
A French TTO acting on behalf major life science research labs in Paris Region, has designed and synthetized a new patented micro-particle which strongly improves the efficacy of a type of vaccines: ribonucleic acid (RNA) vaccines.
The proof... more
This Irish SME has developed an animal warming and drying apparatus, optionally incorporating a radiant energy therapy means on upper & lower diffuser elements each deployable from a folded storage position. A combined air blower and heating... more
showed promising therapeutic results in a mouse model of ovalbumin induced allergy (egg allergy), providing a long-term effectiveness over a 10-month period study.
This treatment also provides a good preventive... more
continuous release of the proteases encapsulated within at therapeutic doses during a sufficient period of time for the treatment of diseases which require a sustained protease administration during treatment... more
modulate the activation of the immune system have, therefore, a great potential in the identification of a therapeutic approach for a multiplicity of neurodegenerative and autoinflammatory pathologies. The inhibition... more
A French Technology Transfer Office (TTO) is acting on behalf several major engineering and medical schools in the Paris region. A research team operating in biochemical has designed a series of peptides acting as anti-inflammatories.
* Market... more
A French Technology Transfer Office (TTO) is acting on behalf of major life science research labs in Paris region, has designed and patented pseudo-viral like particles (VLPs) to prevent and cure allergy or auto-immune diseases like multiple... more
Cervical cancer is the third most common cancer in women world-wide, with approx. 530,000 new cases and 275,000 deaths per year. In contrast to other cancers it mainly affects young women with a maximum of incidence below 30 years of age.
The Japanese company has developed two platform technologies: an in silico drug screening technology for small molecules (#1) and a new modality for therapeutic peptide (#2).
Technology #1 is being powered up... more
An Andalusian University in the south of Spain has developed a combination kit of GAL (1-15) or a pharmaceutically acceptable salt therof useful for augmenting and/or providing faster onset of the therapeutic effect... more
treatment in most of them leads to the continuous search for new therapeutic targets.
LRRK2 is a protein that has been classified as a member of the ROCO superfamily (Ras-like GTPase). Its physiological role is... more
therapeutic interventions with the latest digital solutions in a secure, user friendly web-based environment. It uses a blended approach where therapeutic interventions are supported... more
and it has received very positive feedback from the patients, support groups and medical organizations. It makes a patient's life easier, improves a patient's motivation for treatment and intensifies the therapeutic... more
therapeutic effect, especially in the treatment of tumors resistant to officinal cytostatic.
The dosage of the half maximal inhibitory concentration (IC50, i.e. dose required for the death of 50% of tumor cells)... more
compounds), to be used for therapeutic and non-therapeutic purposes.
The center is looking to establish license, research cooperation or technical cooperation agreements with industrial... more
personalised medicine, medical equipment and experience in the EU medical device or therapeutic markets. The Swiss start-up will take care of the distribution and of the commercialisation whilst each partner will... more
broad menu covering all the currently actionable molecular signatures. A constant update of new drugs/diagnostics development is a major focus of the approach proposed. It allows to immediately exploit the most advanced therapeutic... more
with cytotoxic compounds linked to anti-THSD7A antibodies to optimize site directed drug application and minimize therapeutic side effects.
Due to the strong relation to several tumor entities, THSD7A can be... more